The Study Observes Afatinib as First-line Treatment in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Non-small Cell Lung Cancer
Boehringer Ingelheim · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020